Europe’s recession is causing major drug companies to decrease their forecasts and spending. After EU policymakers accepted a rescue fund in May totaling almost $1 trillion, countries have reduced or plan to reduce their health spending. Germany instituted a price freeze on drugs until 2013, Spain presented a 7.5% rebate on most name-brand products and […]
The International Organization for Standardization (ISO) has released a new technical report on nanomaterials. The ISO/TR 11360:2010 report, “Nanotechnologies—Methodology for the classification and categorization of nanomaterials,” offers a global methodology for nanomaterials classification. It aims to alleviate misunderstandings that scientists and researchers have about nanotechnology, due to its wide range of applications and the diverse […]
A judge’s ruling has stopped about 35% of the US government’s planned allocation of $200 million in grants for embryonic stem cell research this year. The National Institutes of Health (NIH) had planned to distribute $54 million in annual grants in September, in addition to $15–$20 million for new projects. Under President Obama’s order, the […]
Major drug makers have a decision to make regarding entrance to the US biosimilars market. Companies must choose how to develop the drugs. They can develop them as new products, which would involve extensive and expensive clinical trials, or opt for a quicker route, similar to that used by generic drugs. Companies hope to begin […]
Holliston, MA 8/23/10—Harvard Bioscience has acquired substantially all the assets of Coulbourn Instruments for an undisclosed amount. Coulbourn Instruments manufactures behavioral measurement products, with an emphasis on systems for assessing learning and memory utilized in research labs. “The acquisition of Coulbourn provides us another well established brand in our portfolio of products and enables us […]
Washington, DC 8/16/10—DNA sequencer developer Pacific Biosciences has filed a registration form with the SEC for an IPO to raise $200 million. The company’s SMRT (single-molecule real-time) sequencing technology provides single-molecule resolution. The company plans to introduce its PacBio RS system in early 2011 at a list price of $695,000, with an initial focus on […]
Portland, OR 8/16/10; Arlington, VA 8/16/10—FLIR, a developer of advanced sensor technologies, has entered into a definitive merger agreement with ICx Technologies for an aggregate cash purchase price of $274 million. ICx Technologies product offerings include systems for chemical, biological, radiation, nuclear and explosives detection. The offer consists of a cash tender offer for outstanding […]
Waltham, MA 8/31/10—PerkinElmer has signed a definitive agreement to sell its Illumination and Detection Solutions (IDS) business to private equity firm Veritas Capital Fund III for $500 million, or $482 million net of payments for acquired cash balances. The IDS business provides custom-designed specialty lighting and sensor components, subsystems and integration solutions to major OEMs […]
Carlsbad, CA and Guilford, CT 8/17/10—Life Technologies has agreed to buy Ion Torrent for $375 million in cash and stock. Ion Torrent’s PostLight sequencing technology translates chemical signals into digital information on a semiconductor chip. An additional consideration of $350 million cash and stock will be available upon the achievement of certain technical and time-based […]
Billerica, MA 8/16/10; Plainview, NY 8/16/10—Bruker has agreed to acquire Veeco Instruments’ Metrology business, consisting of its scanning probe microscopy (SPM) and optical industrial metrology (OIM) instruments, for $229 million in cash. In 2011, the business is forecast to contribute revenues of more than $130 million and adjusted operating margins of greater than 15%. Bruker […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
